Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.5000
-0.0023 (-0.46%)
At close: Jun 18, 2026, 4:00 PM EDT
0.5150
+0.0150 (3.00%)
After-hours: Jun 18, 2026, 4:26 PM EDT
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $16.71 million as of June 18, 2026. Its market cap has increased by 146.11% in one year.
Market Cap
16.71M
Enterprise Value
-33.63M
1-Year Change
146.11%
Ranking
Category
Stock Price
$0.50
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $16.71M, a decrease of -74.41%. That is a compound annual growth rate of -24.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 16.71M | -43.91% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipocine | 19.13M |
| Atossa Therapeutics | 19.12M |
| Sensei Biotherapeutics | 18.59M |
| Passage Bio | 18.17M |
| Tempest Therapeutics | 18.07M |
| Cellectar Biosciences | 17.98M |
| AEON Biopharma | 17.71M |
| Werewolf Therapeutics | 17.49M |